R 1437
Latest Information Update: 25 Jul 2006
At a glance
- Originator Roche
- Class
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Benign prostatic hyperplasia
Most Recent Events
- 25 Jul 2006 No development reported - Preclinical for Benign prostatic hyperplasia in Europe (unspecified route)
- 17 Apr 2002 Preclinical trials in Benign prostatic hyperplasia in Europe (unspecified route)